32 results
DEFA14A
ZOM
Zomedica Corp
20 Feb 24
Additional proxy soliciting materials
6:12am
at after a very lengthy and careful review of both historical and Zomedica-specific reverse split data with the following target goals:
1- Having
DEFA14A
ZOM
Zomedica Corp
24 Jan 24
Additional proxy soliciting materials
1:38pm
, looking beyond the reverse split, what are Zomedica’s primary goals and strategic initiatives for 2024, and how does the reverse split facilitate … profitability in future quarters.
Specifically, we are focused on a set of ambitious goals and strategic initiatives for 2024.
First, is to continue
8-K
EX-99.1
uk6mxgyhku46wo6
4 Oct 21
Zomedica Appoints Larry Heaton as President and Announces CEO Succession Plan
6:15am
8-K
EX-99.1
gh81ay2t6 ccdn7l
11 Aug 21
Zomedica Announces Second Quarter 2021 Financial Results
4:16pm
424B3
to5vqqhhhh le
26 Oct 20
Prospectus supplement
9:21am
S-4/A
uh6akfvi
22 Oct 20
Registration of securities issued in business combination transactions (amended)
4:01pm
S-4
k5huqkuaulb2pk03a81u
9 Oct 20
Registration of securities issued in business combination transactions
1:57pm
PRE 14A
ddiiro
29 Jul 20
Preliminary proxy
5:25pm